Clinical Trials Logo
  1. Home
  2. Cough Variant Asthma
  3. NCT05459805

Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine

Cough Variant Asthma Clinical Trial

Official title:
Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine

Clinical Trial Summary

To explore the disease outcome prognosis of cough variant asthma by observing the outcomes of cough variant asthma and the effects of Chinese and Western medicine interventions, and to provide a scientific basis for optimizing the treatment protocol of combined traditional and Western medicine for cough variant asthma. This is a multi-center, non-randomized, prospective cohort study. This study started in March 2022 and is going on now. On an informed consent basis, a cohort of 164 patients with diagnosis of CVA are engaged. All patients will receive 8-week treatment (ICS/LABA plus Chinese herbal medicine for trial group while ICS/LABA only for control group) and be observed in next 24 weeks. Patients will be followed up every 2 weeks during treatment period and every 4 weeks in observation.The feasibility and correctness of the study will be supervised by two supervisors. To ensure that participants adhere to their follow-up plans, we remind them of their fixed visiting by phone or message. Additionally, incentives are used to appreciate participants for their cooperation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05459805
Study type Interventional
Source The First Affiliated Hospital of Zhejiang Chinese Medical University
Contact Junchao Yang
Phone +86 13858036093
Email yangjunchaozj@163.com
Status Recruiting
Phase N/A
Start date March 1, 2022
Completion date December 31, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03319043 - Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules. Phase 1/Phase 2
Recruiting NCT04171180 - The Efficacy of Budesonide/Formoterol in Cough Variant Asthma Phase 4
Recruiting NCT03105843 - Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol Phase 4
Unknown status NCT02002754 - The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Phase 4
Not yet recruiting NCT01170429 - Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) Phase 4
Completed NCT04203472 - Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma N/A
Recruiting NCT03169699 - Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data N/A
Completed NCT01064245 - Physiology of Cough in Asthma: Comparison of Sensory-Mechanical Responses to Mannitol and Methacholine Challenge Tests N/A
Completed NCT03363698 - MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic Cough
Completed NCT03573284 - Validity of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma N/A
Completed NCT00660114 - Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients N/A